4T1-derived exosomes downregulate NKG2D expression on NKp46+ splenocytes
Authors:
- Rizan FallahzadehRFRizan Fallahzadeh
- Motahare KhastebandMKMotahare Khasteband
- Jafar RezaieJRJafar Rezaie
- Adel MohammadzadehAMAdel Mohammadzadeh
Open Access
- 6 November 2026
- journal article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 48
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- IMMUNE SENESCENCE AND EXHAUSTION PHENOTYPE MARKED BY LOSS OF NKG2D AND DNAM-1 NK ACTIVATING SIGNALING AND INCREASED TIM-3 T CD8 CHARACTERIZES ADVANCED MYELOFIBROSISHematology, Transfusion and Cell Therapy, 2025
- NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunityCancer Immunology, Immunotherapy, 2024
- Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular CarcinomaBiochemical Genetics, 2023
- Role of tumor microenvironment in cancer progression and therapeutic strategyCancer Medicine, 2023
- Exosomes-mediated tumor metastasis through reshaping tumor microenvironment and distant nicheJournal of Controlled Release, 2022
- Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progressionOncogene, 2022
- Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpointEBioMedicine, 2022
- Exosomes as mediators of intercellular crosstalk in metabolismCell Metabolism, 2021
- CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapyCurrent Opinion in Chemical Engineering, 2017
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001